MDT

89.47

+0.29%↑

VEEV

279.53

-0.5%↓

A

113.32

-3.16%↓

WBA

11.5

-0.09%↓

HQY

96.34

-1.04%↓

MDT

89.47

+0.29%↑

VEEV

279.53

-0.5%↓

A

113.32

-3.16%↓

WBA

11.5

-0.09%↓

HQY

96.34

-1.04%↓

MDT

89.47

+0.29%↑

VEEV

279.53

-0.5%↓

A

113.32

-3.16%↓

WBA

11.5

-0.09%↓

HQY

96.34

-1.04%↓

MDT

89.47

+0.29%↑

VEEV

279.53

-0.5%↓

A

113.32

-3.16%↓

WBA

11.5

-0.09%↓

HQY

96.34

-1.04%↓

MDT

89.47

+0.29%↑

VEEV

279.53

-0.5%↓

A

113.32

-3.16%↓

WBA

11.5

-0.09%↓

HQY

96.34

-1.04%↓

Search

Glaukos Corp

Uždarymo kaina

SektoriusSveikatos priežiūra

98.51 -5.69

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

98.04

Max

103.82

Pagrindiniai rodikliai

By Trading Economics

Pajamos

15M

-18M

Pardavimai

1.2M

107M

Pelno marža

-17.012

Darbuotojai

995

EBITDA

1.6M

-21M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+21.98% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-07-30

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

598M

6B

Ankstesnė atidarymo kaina

104.2

Ankstesnė uždarymo kaina

98.51

Naujienos nuotaikos

By Acuity

50%

50%

154 / 376 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

Glaukos Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-07-15 23:41; UTC

Rinkos pokalbiai

Nikkei May Trade in Range Amid Tariff Uncertainty -- Market Talk

2025-07-15 23:40; UTC

Rinkos pokalbiai

Gold Edges Higher on Possible Position Adjustments -- Market Talk

2025-07-15 23:05; UTC

Rinkos pokalbiai

Auckland International Airport Passenger Growth May Disappoint Again -- Market Talk

2025-07-15 21:36; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-07-15 21:36; UTC

Rinkos pokalbiai

Canada CPI Data Fuel Rate-Prediction Revisions -- Market Talk

2025-07-15 20:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2025-07-15 20:50; UTC

Rinkos pokalbiai
Uždarbis

Financial Services Roundup: Market Talk

2025-07-15 20:50; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2025-07-15 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-07-15 20:14; UTC

Įsigijimai, susijungimai, perėmimai

Chinese EV Makers to Combine. Geely Is Buying Zeekr. -- Barrons.com

2025-07-15 20:07; UTC

Uždarbis

BlackRock Shares Tumble After Big Client Redemption Blunts Quarterly Results -- Update

2025-07-15 20:06; UTC

Rinkos pokalbiai

Nvidia, AMD Seen Benefiting from Return to Chinese Chip Sales -- Market Talk

2025-07-15 19:54; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-07-15 19:54; UTC

Rinkos pokalbiai

Meta CEO Hints at Higher Revenues, Expenses With Data Center Plans -- Market Talk

2025-07-15 19:38; UTC

Rinkos pokalbiai

Oil Falls As Eventual Oversupply Concerns Weigh -- Market Talk

2025-07-15 19:09; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Post Back-to-Back Gains -- Market Talk

2025-07-15 19:07; UTC

Rinkos pokalbiai

Canada CFOs Willing to Take Risks, Increase Spending -- Market Talk

2025-07-15 19:03; UTC

Rinkos pokalbiai

Gold Slips as Big Buyers Pull Back -- Market Talk

2025-07-15 18:32; UTC

Įsigijimai, susijungimai, perėmimai

Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks -- Analysis

2025-07-15 18:31; UTC

Įsigijimai, susijungimai, perėmimai

Waters Deal for Becton Unit Pairs Near-Term Risks With Possible Long-Term Rewards, Analysts Say

2025-07-15 18:13; UTC

Rinkos pokalbiai

Canada Adopts 'Note of Realism' in US Trade Talks, Setting Stage for Possible Tariff Deal -- Market Talk

2025-07-15 17:40; UTC

Rinkos pokalbiai

Canadian Inflation Adds to Case for Bank of Canada Extending Pause -- Market Talk

2025-07-15 17:40; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-07-15 17:25; UTC

Įsigijimai, susijungimai, perėmimai

National Fuel Gas Gets Rare Double Upgrade. Buy the Stock, Analyst Says. -- Barrons.com

2025-07-15 17:24; UTC

Rinkos pokalbiai

Dollar Gains Strength After Inflation Data -- Market Talk

2025-07-15 16:49; UTC

Rinkos pokalbiai

Oil Futures Likely to Continue Sideways Trade -- Market Talk

2025-07-15 16:20; UTC

Rinkos pokalbiai
Uždarbis

Financial Services Roundup: Market Talk

2025-07-15 16:20; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2025-07-15 16:20; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-07-15 15:42; UTC

Rinkos pokalbiai

Coca-Cola Seen as Top Pick Ahead of Consumer Staples Earnings -- Market Talk

Akcijų palyginimas

Kainos pokytis

Glaukos Corp Prognozė

Kainos tikslas

By TipRanks

21.98% į viršų

12 mėnesių prognozė

Vidutinis 127.09 USD  21.98%

Aukščiausias 165 USD

Žemiausias 86 USD

Remiantis 12 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Glaukos Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

12 ratings

11

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

87.61 / 93Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bearish Evidence

Rinkos nuotaikos

By Acuity

154 / 376 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Glaukos Corp

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.